NCT03601806: Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection |
|
|
| Active, not recruiting | 2 | 26 | RoW | Laboratory Biomarker Analysis, Pomalidomide, 4-Amino thalidomide, Actimid, CC-4047, Imnovid, Pomalyst | AIDS Malignancy Consortium, National Cancer Institute (NCI), The Emmes Company, LLC, University of Arkansas, Montefiore Medical Center, University of Stellenbosch, Weill Medical College of Cornell University, University of California, Los Angeles | Human Immunodeficiency Virus 1 Positive, Skin Kaposi Sarcoma | 11/24 | 01/26 | | |
NCT04577755: Pomalidomide Treatment in Patients With Kaposi Sarcoma |
|
|
| Recruiting | 2 | 45 | US | Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Pomalidomide, 4-Aminothalidomide, Actimid, CC-4047, CC4047, Imnovid, Pomalyst, X-Ray Imaging, Conventional X-Ray, Diagnostic Radiology, Medical Imaging, X-Ray, Plain film radiographs, Radiographic Imaging, Radiographic imaging procedure (procedure), Radiography, RG, Static X-Ray, X-Ray | National Cancer Institute (NCI) | Skin Kaposi Sarcoma | 03/26 | 03/26 | | |
